Mitran K.
- Country
- The Netherlands
- Department
- Cardiology
Research Overview
Data & Insights
Has run more than one trial at 0 of 31 partner sites.
Specializations
Atherosclerotic Cardiovascular Disease
Focuses on the diagnosis, risk stratification, and treatment of Atherosclerotic cardiovascular disease in adult patients.
- Peripheral arterial disease
- Acute myocardial infarction
- Coronary heart disease
Emphasizes integration of preventive strategies with emerging pharmacologic options.
Lipid and Metabolic Therapeutics
Investigates therapeutic approaches targeting dyslipidaemia and metabolic risk factors associated with cardiovascular events.
- Elevated lipoprotein(a)
- Hypertriglyceridemia
- Obesity and overweight
Research includes evaluation of novel agents that modify lipid profiles and improve metabolic health.
Arrhythmia and Thromboembolic Prevention
Dedicated to reducing stroke and systemic embolism risk in patients with cardiac rhythm disorders.
- Atrial fibrillation
- Venous thromboembolism
- Stroke prevention
Evaluates anticoagulant and antiplatelet strategies within the context of cardiovascular comorbidities.
Heart Failure and Renal Protection
Explores interventions aimed at improving outcomes for patients with chronic heart failure and concurrent renal impairment.
- Heart failure with preserved ejection fraction
- Kidney failure
- Cardiorenal syndrome
Combines cardiovascular and nephrology perspectives to address combined disease burden.
Cardiovascular Impact of Infectious and Inflammatory Conditions
Assesses how acute infections and systemic inflammation influence cardiovascular risk and event rates.
- Pneumonia
- Influenza
- Sepsis
Investigates adjunctive therapies that may mitigate cardiovascular complications during infectious episodes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.